Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α
Mitotane is the cornerstone of medical treatment of adrenocortical carcinoma. Estrogenic-like side effects frequently occur in patients, and previous studies explored the chemical nature of the interaction between estrogen receptor-α (ER-α) and toxic compounds, including the DDD derivatives. We used...
Hlavní autoři: | , , , , , , , , , |
---|---|
Médium: | Článek |
Jazyk: | English |
Vydáno: |
MDPI AG
2021-06-01
|
Edice: | Biomedicines |
Témata: | |
On-line přístup: | https://www.mdpi.com/2227-9059/9/6/681 |